Find therapies in clinical trials near you – page 39

Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Study on the Safety and Effectiveness of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Study on the Safety and Effectiveness of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Study on Early Treatment with Teclistamab and Talquetamab for Patients with Newly Diagnosed High-Risk Multiple Myeloma

Study on Early Treatment with Teclistamab and Talquetamab for Patients with Newly Diagnosed High-Risk Multiple Myeloma

Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

Study on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery

Study on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery

Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

Study Comparing Degarelix and Drug Combination with Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Study Comparing Degarelix and Drug Combination with Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Study of IMC-M113V for Patients with Chronic HIV Infection Who Are Virologically Suppressed

Study of IMC-M113V for Patients with Chronic HIV Infection Who Are Virologically Suppressed

Study of BI-1206, Rituximab, and Acalabrutinib for Patients with Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma

Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis